Pangenomic Health Inc.
PGHIF
$1.46
$0.3632.74%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -69.30% | 3.70% | |||
| Gross Profit | 69.30% | -3.70% | |||
| SG&A Expenses | 491.42% | 11.05% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 289.92% | 8.29% | |||
| Operating Income | -289.92% | -8.29% | |||
| Income Before Tax | -346.08% | -2.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -346.08% | -2.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -346.08% | -2.79% | |||
| EBIT | -289.92% | -8.29% | |||
| EBITDA | -290.02% | -8.29% | |||
| EPS Basic | -299.03% | 46.63% | |||
| Normalized Basic EPS | -297.67% | 46.47% | |||
| EPS Diluted | -299.03% | 46.63% | |||
| Normalized Diluted EPS | -297.67% | 46.47% | |||
| Average Basic Shares Outstanding | 11.79% | 92.66% | |||
| Average Diluted Shares Outstanding | 11.79% | 92.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||